EPA and DHA Omega-3 Ingredient Market

EPA and DHA Omega-3 Ingredient Market Analysis by Technical Grade, Food Grade, Pharma Grade, and Feed Grade from 2023 to 2033

Analysis of EPA and DHA Omega-3 Ingredient Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

EPA and DHA Omega-3 Ingredient Market

Increasing at a CAGR of 7.2%, the global EPA and DHA omega-3 ingredient market is projected to grow from a value of US$ 3.06 billion in 2023 to US$ 6.13 billion by the end of 2033.

EPA and DHA are types of omega-3 fatty acids, which are essential nutrients that play a crucial role in human health. EPA stands for Eicosapentaenoic Acid, and DHA stands for Docosahexaenoic Acid. These omega-3 fatty acids are commonly found in various foods, especially in fish and other seafood.

EPA and DHA omega-3 ingredients typically refer to concentrated forms of these fatty acids extracted from marine sources, such as fish oil or algae. They are used in various products, including dietary supplements, pharmaceuticals, and functional foods. These ingredients are popular because of the many potential health benefits associated with omega-3 fatty acids.

  • EPA and DHA can help reduce the risk of heart disease by lowering blood pressure, triglycerides, and the risk of abnormal heart rhythms.
  • DHA is essential for brain development in infants and can support cognitive function in adults.
  • Omega-3 fatty acids have anti-inflammatory properties and can be beneficial for conditions involving chronic inflammation, joint pain, and stiffness in conditions such as rheumatoid arthritis.

Demand for fish oil-based omega-3 products is experiencing a healthy growth. Rising awareness of health consciousness is leading to growing demand for products that offer a wide range of health benefits. Omega-3 fatty acids, particularly EPA and DHA found in fish oil, are associated with numerous health advantages, including heart health, brain function, and joint support. Thus, the growing awareness of health and wellness is a primary driver for the increasing demand for fish oil-based omega-3 products.

  • Several research studies have consistently demonstrated the positive impact of omega-3 fatty acids on health.
  • Several published studies and clinical trials have reinforced the association between omega-3 consumption and reduced risk of chronic conditions such as cardiovascular diseases, cognitive decline, and inflammatory disorders. The robust scientific evidence is elevating consumers’ confidence in the efficacy of fish oil-based omega-3 products.

Fact.MR also predicts that the rising trend of sustainability and veganism will drive up the demand for non-fish omega-3 products over the next 10 years. This trend is also forecasted to boost the sales of omega-3 products sourced from plant-based resources such as walnut, mustard, chia, and more.

In addition to plant-based sources, the cultivation of algae is becoming increasingly popular among manufacturers because it offers a more sustainable approach to producing omega-3 ingredients. This method relies on photosynthesis rather than fermentation for production, resulting in the absence of challenging-to-dispose toxins.

Report Attributes Details
EPA and DHA Omega-3 Ingredient Market Size (2023E) US$ 3.06 Billion
Forecasted Market Value (2033F) US$ 6.13 Billion
Global Market Growth Rate (2023 to 2033) 7.2% CAGR
Leading Regional Market North America
Key Companies Profiled
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • Clover Corporation Ltd
  • Croda International Plc
  • Novotech Nutraceuticals
  • Omega Protein Corporation
  • Cargill Inc.
  • Epax Norway AS
  • GC Rieber Oils AS
  • Pharma Marine AS
  • Copeinca ASA
  • Arista Industries Inc.
  • Polaris Nutritional Lipids
  • Marine Ingredients LLC
  • Barleans Organic Oils L.L.C.
  • Algaecytes Limited
  • Qualitas Health
  • Cellana, Inc.
  • Qponics Limited, BioProcess Algae, LLC
  • Luhua Biomarine (Shandong) Co., Ltd
  • Denomega Nutritional Oils

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What’s Helping Manufacturers of EPA and DHA Omega-3 Ingredients?

“Preventive Healthcare with Dietary Supplements Rendering New Possibilities for EPA and DHA Omega-3 Ingredient Providers”

The trend of 'preventive healthcare' is increasing, and modern consumers are harnessing the power of dietary supplements to jump onto this bandwagon. The new-age consumers are becoming highly ‘self-directed’ and the way they arrive at purchasing decisions has drastically transformed over the years. Brands offering dietary supplements are catching up with this dynamic trend via the use of active ingredients, which is likely to propel the growth of the EPA and DHA omega-3 ingredient market over the next decade.

This preventive healthcare trend is being set in motion by online forums, magazines, and social media platforms, which dispense lifestyle and dietary bits of advice regularly. This barrage of information contributes toward shaping consumer preferences in favor of EPA and DHA omega 3 ingredient-infused products, thereby encouraging dietary supplement brands to invest in these ingredients.

In addition, increasing focus of dietary supplement brands on refashioning their marketing strategies with ‘value-adds’ being their key marketing proposition. This, in turn, is also setting the stage for high consumption of EPA and DHA Omega 3 ingredients in 2023 and beyond.

“Growing Demand for Omega-3-based Nutritional Products for Infants”

Infant nutrition is at the cusp of crucial shifts in the ingredients being used, as the trend of ‘functional fortification’ is spreading its roots in the space of neonatal nutrition. The use of Essential Fatty Acids (EFA), which is well-known for their contribution toward cellular metabolism, is gaining momentum as precursors nourishing the cognitive and cardiovascular health of infants. Omega-3 derivatives, primarily DHA, have firmly established themselves as ‘brain nourishing’ ingredients used in infant formulas, and this adoption is further estimated to scale new heights in 2023 and the coming 10 years.

Growing population of working mothers is giving an impetus to the sales of infant formulas infused with high-quality functional ingredients. As working mothers are on a constant lookout for alternatives matching up with the nutritional value of human milk, the adoption of EPA and DHA omega-3 ingredients in infant food is estimated to be on a tear for the next 10 years.

Will Lengthy Regulatory Approvals Remain a Challenge for EPA and DHA Omega-3 Ingredient Manufacturers?

“Multi-phase Product Approval Process Hampering Market Growth Progress”

Though regulations can play a crucial role in fostering long-term adoption of a product, ‘multi-phased’ regulatory approvals can potentially hamper large-scale penetration of the same. Multiple phases in the overall regulatory approval process of EPA and DHA omega-3 ingredients adversely impact the ‘time-to-market’ variable, and a lack of compliance with any of these regulatory phases can completely close off opportunities for the market players.

  • The initial stage of laboratory and animal testing, followed by detailed clinical research and FDA examination makes the overall procedure of regulatory approvals way too long, posing a myriad of challenges for the producers.
  • After the three-staged testing, the FDA also conducts a post-market drug safety of the concerned product, wherein it closely examines the safety parameters after they are commercialized for consumption.

Also, to deal with these challenges, some manufacturers active in the EPA and DHA omega-3 ingredient market are focusing on end-to-end adherence to the manufacturing process with the established set of rules, which can help them gain competitive advantages over their rivals.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

How Can New Companies Infuse Creativity to Stand Out in This Competitive Field?

“Start-ups Can Sail Smoothly through with Product Innovations and Collaborations”

Newcomers entering the EPA and DHA omega-3 ingredient market can face a competitive landscape, but adopting several strategies can help them earn more and establish a strong foothold.

The most common yet successful way for newcomers to stand out is by offering innovative omega-3 products that cater to specific consumer needs. This could include unique formulations, delivery methods, or value-added features that set their products apart from established brands.

Emphasizing the quality and purity of their EPA and DHA omega-3 ingredients can help new companies build trust with consumers. Rigorous testing, sustainable sourcing, and certification for purity can be compelling selling points.

Collaborations with established players in the industry can open doors for newcomers. Partnerships with ingredient suppliers, manufacturers, or distributors can provide access to distribution networks and expertise that would be otherwise challenging to establish independently.

Investment in research and development is key. Fact.MR’s report reveals detailed information on the latest trends and opportunities in the EPA and DHA omega-3 ingredient industry.

Country-wise Analysis

According to Fact.MR, a market research and competitive intelligence provider, demand for EPA and DHA omega-3 ingredients in the United States, Germany, and Japan is underpinned by health consciousness, regulatory support, a strong emphasis on quality and purity, and aging populations. Each of these countries exhibits unique market dynamics, but all are experiencing healthy demand for omega-3 products driven by the pursuit of health and well-being.

What is Influencing the Demand for EPA and DHA Omega-3 Supplements in the United States?

“Large Health-conscious Consumer Base and Positive Regulatory Support”

The United States market for EPA and DHA omega-3 ingredients is experiencing healthy growth due to an increasingly health-conscious population. As Americans are becoming more aware of the health benefits associated with omega-3 fatty acids, there is a growing demand for supplements and fortified foods containing these ingredients.

  • On June 19, 2019, the United States FDA approved qualified health claims endorsing that EPA and DHA omega-3 consumption in food or supplements may reduce the risk of coronary heart disease and hypertension.

The United States Food and Drug Administration (FDA) has also approved health claims related to omega-3s, particularly EPA and DHA, which can be used in marketing and labeling. This regulatory support is enhancing consumer trust and driving EPA and DHA omega-3-based product sales.

What is Increasing Sales of Omega-3 Supplements in Germany?

“Pharmaceutical Channels Playing Major Role in Fish Oil-based Nutritional Supplement Sales”

Germany has a strong culture of health and wellness, and the population is highly health-conscious. Many German doctors recommend omega-3 supplements, especially for cardiovascular health. These recommendations contribute to consumer awareness and drive product adoption.

In Germany, omega-3 supplements are often available through pharmaceutical channels. This distribution channel, combined with the country's healthcare system, is contributing to the widespread availability and use of omega-3 products.

How are Sales of Omega-3 Supplements Evolving in Japan?

“Seafood Being Major Diet Source Aiding in Easy Adoption of Omega-3-based Supplements”

Japan is known for its aging population and emphasis on healthy aging. Omega-3 ingredients, with their potential to support cognitive health and reduce the risk of heart disease, align with the country's focus on longevity and well-being.

Japan's traditional diet includes a significant amount of seafood, which is naturally rich in EPA and DHA. This dietary habit has translated into consumer awareness of the health benefits of these fatty acids, further fuelling the demand for omega-3-based products.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Analysis

Swiftly increasing demand for omega-3-based dietary supplements can be attributed to the growing awareness of their health benefits, medical recommendations, lifestyle trends, and more. However, the demand for EPA and DHA omega-3-based infant formulas is also predicted to gain momentum in the coming decade.

Why is Demand for Omega-3 Dietary Supplements Increasing Rapidly?

“Growing Awareness of Health Benefits and Lifestyle Changes Increasing Consumption of Omega-3 Dietary Supplements”

Omega-3 fatty acids, particularly EPA and DHA, are associated with various health benefits, including cardiovascular health, cognitive function, joint support, and reduced inflammation. Consumers are increasingly aware of these advantages and seek supplements to support their well-being. Many healthcare professionals recommend omega-3 supplements to patients, especially for individuals with heart health concerns. This medical endorsement is driving consumer interest in these supplements.

Rise in health-conscious lifestyles, including fitness and wellness routines, is also leading to high interest in supplements that can enhance overall health and performance. Omega-3s are seen as a valuable addition to such lifestyles.

Competitive Landscape

Leading EPA and DHA omega-3 ingredient companies are working on influential marketing- a game-changer deciding their fate in the competitive market space.

Brands are exploring inventive packaging strategies as a strategic marketing tool, enabling them to influence consumer choices and gain a competitive edge. With the rapidly rising demand for functional ingredients, industry participants must innovate in product development while maintaining their core strengths.

Manufacturers are also shifting their strategic focus toward alliances, primarily mergers, and acquisitions, to expand their technology and manufacturing bases and successfully meet the market demand for high-quality EPA and DHA omega-3 ingredients in response to label expansions and favorable clinical research.

  • For instance, in 2018, KD Pharma Group unveiled the launch of two of its exclusive DHA and EPA omega-3 ingredients for use in multiple applications, including food and beverages, dietary supplements, infant nutrition, and animal feed.
  • In September 2021, KD Pharma Group started the commercialization of Alga3, a vegan omega-3 solution.
  • Polaris showcased Omegavie DHA 800 Sensory Qualitysilver 5 algae, in June 2021. The product consists of a high-concentration microalgae DHA ingredient. This algae oil, Schizochytrium sp. sourced, is rich in proteins, pigments, vitamins, and enzymes.

Market players are also focusing on a few of the untapped corners in the personal care and cosmetics market, as the use of omega-3 ingredients in personal care is on its way to outgrow its phase of dormancy.

Key Segments of EPA and DHA Omega-3 Ingredient Market Research

  • By Source :

    • Fish Oil
    • Algae Oil
  • By Grade :

    • Technical Grade
    • Food Grade
    • Pharma Grade
    • Feed Grade
  • By End Use :

    • Food & Beverages
    • Dietary Supplements & Nutraceuticals
    • Infant Formula
    • Pharmaceuticals & Clinical Nutrition
    • Animal Feed
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

- FAQs -

How big is the EPA and DHA omega-3 ingredient market in 2023?

The global EPA and DHA omega-3 ingredient market is valued at US$ 3.06 billion in 2023.

What will the EPA and DHA omega-3 ingredient market size be by 2033?

Worldwide sales of EPA and DHA omega-3 ingredients are projected to reach US$ 6.13 billion by 2033.

What is the forecasted CAGR for the global market?

Global demand for EPA and DHA omega-3 ingredients is forecasted to increase at a CAGR of 7.2% from 2023 to 2033.

Who are the leading manufacturers of EPA and DHA omega-3 ingredients?

Some of the top companies in the market are KD Pharma Group, Polaris, and Corbion NV.

Which omega-3 is the best EPA or DHA?

DHA exhibits a more potent anti-inflammatory impact compared to EPA.

EPA and DHA Omega-3 Ingredient Market

Schedule a Call